Share of new combination therapies available in Europe in 2023, by country
This statistic displays the share of combination therapies approved by the European Medicines Agency (EMA) between 2018 and 2021 which were available to patients in selected European countries as of January 5, 2023. According to the data, 77 percent of approved combination therapies were available to patients in Finland.